Keywords
Covid-19
Risk factors
Prognosis
Critical care
Respiratory insufficiency
Death
How to Cite
Abstract
Background and purpose: Diabetes mellitus is one of the most prevalent chronic non-communicable diseases in the world and it is frequently reported in patients with COVID-19. It is not clear if people with diabetes mellitus have a higher risk of infection or if once infected, they have a worse prognosis. Our purpose was to review and analyze the available information on COVID-19 and diabetes mellitus and try to better understand the risk to which people with diabetes mellitus are exposed during the COVID-19 pandemic.
Methods: PubMed, Cochrane Database of Systematic Reviews, Google Scholar, Scopus, and Epistemonikos were reviewed for national epidemiological records and systematic reviews using the terms “Diabetes Mellitus”, “COVID-19”, “Risk Factors”, “Prognosis”, “Critical Care”, “Respiratory Insufficiency” and “Death”. Systematic reviews of comorbidities in patients with COVID-19, those that analyzed the course of the disease and prognostic factors in patients with COVID-19, and those that included prognostic models were selected for review.
Results: The available information suggests that diabetes mellitus is a frequent comorbidity in people with COVID-19, but it is difficult to differentiate whether this is due to the high prevalence of diabetes mellitus or a higher risk of infection. People with diabetes mellitus appear to be at a greater risk of severe COVID-19 or dying from COVID-19.
References
2. Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review. Ann Intern Med. 2020;M20-1301. doi:10.7326/M20-1301.
3. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-51. doi:10.3760/cma.j.issn.0254-6450.2020.02.003.
4. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.
5. Red Nacional de Vigilancia Epidemiológica. Informe sobre la situación de COVID-19 en España. Informe COVID-19 no 26. 27 de abril de 2020 [Interner]. Disponible en: https://bit.ly/3cdtzr8.
6. COVID-19 Surveillance Group I. Characteristics of COVID-19 patients dying in Italy: Report based on available data on March 20th, 2020 [Internet]. Disponible en: https://bit.ly/2TNE51W.
7. CDC COVID-19 Response Team. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -- United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(13):382-6. doi:10.15585/mmwr.mm6913e2.
8. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91-5. doi:10.1016/j. ijid.2020.03.017.
9. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.
10. Fang Z, Yi F, Wu K, Lai K, Sun X, Zhong N, et al. Clinical Characteristics of 2019 Coronavirus Pneumonia (COVID-19): An Updated Systematic Review [Internet]. medRxiv. 2020. Disponible en: https://bit.ly/2XFVyKK. doi: https://doi.org/10.1101/2020.03.07.20032573.
11. Yaqian M, Lin W, Wen J, Chen G. Clinical and pathological characteristics of 2019 novel coronavirus disease (COVID-19): a systematic review. medRxiv. 2020. Disponible en: https://bit.ly/2XbPBWI. doi: https://doi.org/10.1101/2020.02.20.20025601.
12. Nasiri MJ, Haddadi S, Tahvildari A, Farsi Y, Arbabi M, Hasanzadeh S, et al. COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis. medRxiv. 2020. Disponible en: https://bit.ly/3dgOQBh. doi: https://doi.org/10.1101/2020.03.24.20042903.
13. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, VillamizarPeña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;34:101623. doi:10.1016/j.tmaid.2020.101623.
14. Parohan M, Yaghoubi S, Seraj A, Javanbakht MH, Sarraf P, Djalali M. Risk factors for mortality of adult inpatients with Coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis of retrospective studies. medRxiv. 2020. Disponible en: https://bit.ly/2AfDgI9. doi: https://doi.org/10.1101/2020.04.09.20056291.
15. Zhao X, Zhang B, Li P, Ma C, Gu J, Hou P, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv. 2020. Disponible en: https://bit.ly/2XGJU23. doi: https://doi.org/10.1101/2020.03.17.20037572,
16. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020;S0163-4453(20)30234-6. doi:10.1016/j.jinf.2020.04.021.
17. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049-57. doi:10.18632/aging.103000.
18. Wynants L, Van Calster B, Bonten MM, Collins GS, Debray TP, De Vos M, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. doi:10.1136/ bmj.m1328.
Authors must state that they reviewed, validated and approved the manuscript's publication. Moreover, they must sign a model release that should be sent. A copy may be reviewed here